Yokohama, Japan

Mayumi Ando

This inventor holds 2 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1987-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1987-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mayumi Ando: Innovator in Enzyme Technology

Introduction

Mayumi Ando is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of enzyme technology, particularly in the development of novel enzymes that have applications in medical diagnostics.

Latest Patents

Mayumi Ando holds 2 patents. Her latest patents include a novel acetylpolyamine amidohydrolase, which specifically hydrolyzes the amino bond in acetylputrescine, acetylcadaverine, acetylspermidine, and acetylspermine with strong substrate affinity. This enzyme is preferably produced by culturing a microorganism belonging to the genus Mycoplana and is used in the quantitative determination of polyamines contained in living body samples, which is useful for cancer diagnosis. Another significant patent is the process for producing bilirubin oxidase, which further showcases her innovative work in enzyme production.

Career Highlights

Mayumi Ando is associated with Kyowa Hakko Kogyo Co., Ltd., where she continues to advance her research and development efforts. Her work has been instrumental in enhancing the understanding and application of enzymes in various fields.

Collaborations

She collaborates with notable colleagues, including Takayuki Uwajima and Kinya Fujishiro, contributing to a dynamic research environment that fosters innovation.

Conclusion

Mayumi Ando's contributions to enzyme technology and her innovative patents highlight her role as a leading inventor in her field. Her work not only advances scientific knowledge but also has practical applications in cancer diagnosis, showcasing the importance of her research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…